Early cardiac evaluation reverses atherosclerosis caused by cardiac risk factors like high BP and high cholesterol in young adults.
Younger people are vulnerable to cardiac risk factors such as elevated blood cholesterol and hypertension, which can lead to atherosclerosis in later life. Early cardiac assessment and risk factor control can reverse the atherosclerosis condition, reveals a new study. Atherosclerosis is the formation of plaques due to deposition of fats in the inner wall of coronary arteries that restricts blood flow to heart muscles, resulting in heart attack and associated disorders.
‘Screening for subclinical atherosclerosis from an early age together with aggressive risk-factor control could help to reduce the global burden of cardiovascular disease. #hypertension #cholesterol #cardiovascularrisk #atherosclerosis #coronarycare #healthyheart’
This new research was conducted at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), and the findings were published in the Journal of the American College of Cardiology (1✔ ✔Trusted SourceDeterminants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
Go to source).
Significance of Early Cardiac Risk Assessment in Young People
Young people may be more susceptible to the effects of the risk factors for developing atherosclerosis.Subclinical atherosclerosis often progresses in middle-aged individuals, especially if LDL-cholesterol levels and blood pressure are even mildly or moderately elevated. Medical professionals and the general public need to be aware that atherosclerosis progression can be stopped if risk factors are managed aggressively from an early age.
Dr. Ibáñez explained that “in this study, we show that moderate increases in blood pressure and cholesterol have a much more pronounced impact on atherosclerosis progression in younger people.”
Very few studies have investigated the progression of silent atherosclerosis in people who are completely free of symptoms, whether they are young or in apparently healthy middle-age, and how this disease progresses throughout life.
Advertisement
Participants also provided blood samples for advanced genomic, proteomic, and metabolomic analysis. “The PESA study has already made important contributions to our understanding of cardiovascular disease and is considered the most advanced study of its kind in the field,” said Dr. Fuster.
Advertisement
And as Dr. Borja Ibáñez emphasized, “these results point the way to personalized approaches that use imaging technology to monitor the presence and progression of silent atherosclerosis and guide the intensity of risk-factor control.”
Cardiologist Guiomar Mendieta, the first author on the study, added that “the other key finding of this study is that atherosclerosis, previously believed to be irreversible, can disappear if risk factors are controlled from an early stage.”
“These findings are the outcome of the exhaustive collection of imaging and biochemical data over 6 years, combined with an innovative statistical analysis,” explained Dr. Mendieta, who joined the CNIC through the CARDIOJOVEN SEC-CNIC training program, a joint initiative of the CNIC and the Spanish Society of Cardiology.
Reference:
- Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years - (https://www.jacc.org/doi/full/10.1016/j.jacc.2023.09.814#)